Correlation between leukocyte count and infarct size in ST segment elevation myocardial infarction

Area of Science:

• Cardiology
• Inflammatory Mechanisms in Cardiovascular Disease
• Biomarker Analysis

Background:

• Inflammatory mechanisms are crucial in ischemic heart disease.
• Leukocyte count is being studied for its association with prognosis and mortality in ST-segment elevation myocardial infarction (STEMI).
• Understanding the relationship between leukocyte count and infarct size is vital for patient outcomes.

Purpose of the Study:

• To correlate the rise in leukocyte count with the size of STEMI.
• To evaluate STEMI size using the area under the curve (AUC) and peak release of necrosis markers.
• To investigate the predictive value of leukocyte count in STEMI.

Main Methods:

• Sub-analysis of the TETHYS clinical trial data.
• Pearson's correlation used for quantitative variables; logarithmic transformation applied for non-normally distributed data.
• Statistical significance determined by p < 0.05.

Main Results:

• Leukocyte count at hospital admission significantly correlated with creatine kinase (CK) AUC, troponin AUC, peak CK, and peak troponin.
• Leukocyte count at 72 hours also showed significant correlations with CK AUC, CK-MB AUC, and peak CK.
• The study population comprised 73% males, with an average age of 59, and significant prevalence of hypertension (58%) and smoking (53%).

Conclusions:

• White blood cell count is a significant correlate of STEMI size.
• Serial cardiac biomarker levels, including CK and troponin, effectively assess STEMI size in relation to leukocyte count.
• Leukocyte count serves as a valuable indicator in assessing myocardial infarction severity.